Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care

By afschroeder • July 10, 2025

El Rafei A, Gosch K, Manning ES, Ghajar A, Raghavan S, Maddox TM, Peterson PN, Fleming L, Arnold SV, Chan PS, Greene SJ, Fonarow GC, Jones PG, Allen LA, Hess PL. Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care. JAMA Cardiol. 2025 Jul 9. doi: 10.1001/jamacardio.2025.2145. Epub ahead of print. PMID: 40632519.

Tags: Cardiology/Epi, Publications

Diet patterns are associated with progression of coronary artery calcification and differ across race/ethnicity: The Multi-Ethnic Study of Atherosclerosis

Momin M, Baylin A, Garner J, Watson K, Inoue K, Brandt EJ. Diet patterns are associated with progression of coronary artery calcification and differ across[...]

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis and Framingham Heart Study

Naghavi M, Azimi A, Atlas K, Reeves AP, Zhang C, Mirjalili SR, Mozafarybazargany M, Jolfayi AG, Hashemi A, Atlas T, Wasserthal J, Vliegenthart R, Henschke[...]

A Knowledge Graph Framework for Longitudinal Congenital Heart Disease Modeling: Methodology Corner

Xu H, Cunge L, Ming Z, Chen S, Husain M, Renella P, Lluri G, Finn JP, Hsu W, Nguyen KL. A Knowledge Graph Framework for[...]